The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

GSK on Monday said that the European Medicines Agency has agreed to review a request to approve the British drugmaker's ...

(Reuters) -A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool ...

An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 ...

The European Medicines Agency accepts GSK's regulatory filing for expanded use of Nucala to treat COPD for review.

Patients and budgets usually come first when deciding which drug is prescribed. But what if the most environmentally sustainable product also benefited the patient?

Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...

CStone Pharmaceuticals ('CStone', HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application to the ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs Ramat Gan, Israel, March ...

The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...

Today marks World TB Day 2025 with the WHO calling for more investment into TB treatment and research globally.

The European Medicines Agency (EMA) has advised that the drug can be used together with diet and physical activity to help ...